Sishiyao Group (02005.HK) has obtained drug production registration approvals from the National Medical Products Administration for Ammonium Chloride Sodium Injection (100ml) and Levocarnitine Oral Solution (10ml).

China's National Medical Products Administration (NMPA) has granted Shisanyao Group (02005.HK) the drug production registration for Ammonium Mefenamic Chloride Injection (100ml), which is classified as a Category 3 chemical drug and is considered to have passed the consistency evaluation. Ammonium Mefenamic Chloride Injection is mainly used to treat various types of bleeding caused by acute or chronic, localized or systemic excessive fibrinolysis.